AR049059A1 - Composiciones farmaceuticas de 4-(4bromo-2fluroanilino)-6-metoxi-7-(1-metilpiperidin-4ilmetoxi)quinazolina - Google Patents
Composiciones farmaceuticas de 4-(4bromo-2fluroanilino)-6-metoxi-7-(1-metilpiperidin-4ilmetoxi)quinazolinaInfo
- Publication number
- AR049059A1 AR049059A1 ARP050102087A ARP050102087A AR049059A1 AR 049059 A1 AR049059 A1 AR 049059A1 AR P050102087 A ARP050102087 A AR P050102087A AR P050102087 A ARP050102087 A AR P050102087A AR 049059 A1 AR049059 A1 AR 049059A1
- Authority
- AR
- Argentina
- Prior art keywords
- methylipiperidin
- 4ilmetoxy
- quinazolina
- metoxi
- 4bromo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Una composicion farmacéutica que comprende ZD6474, o una sal de éste aceptable para el uso farmacéutico, un diluyente frágil, como por ejemplo fosfato de calcio dibásico y un segundo diluyente que es prácticamente insoluble y tiene propiedades de compresion ductil, como por ejemplo celulosa microcristalina, que presenta actividad antitumoral.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0411378.3A GB0411378D0 (en) | 2004-05-21 | 2004-05-21 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049059A1 true AR049059A1 (es) | 2006-06-21 |
Family
ID=32607743
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102087A AR049059A1 (es) | 2004-05-21 | 2005-05-20 | Composiciones farmaceuticas de 4-(4bromo-2fluroanilino)-6-metoxi-7-(1-metilpiperidin-4ilmetoxi)quinazolina |
ARP170103128A AR110045A2 (es) | 2004-05-21 | 2017-11-09 | Composiciones farmacéuticas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170103128A AR110045A2 (es) | 2004-05-21 | 2017-11-09 | Composiciones farmacéuticas |
Country Status (34)
Country | Link |
---|---|
US (1) | US8067427B2 (es) |
EP (1) | EP1753431B1 (es) |
JP (1) | JP4740947B2 (es) |
KR (1) | KR101192935B1 (es) |
CN (1) | CN101031303B (es) |
AR (2) | AR049059A1 (es) |
AT (1) | ATE439841T1 (es) |
AU (1) | AU2005244650B2 (es) |
BR (1) | BRPI0511253B8 (es) |
CA (1) | CA2565513C (es) |
CY (1) | CY1109500T1 (es) |
DE (1) | DE602005016105D1 (es) |
DK (1) | DK1753431T3 (es) |
ES (1) | ES2330025T3 (es) |
GB (1) | GB0411378D0 (es) |
HK (1) | HK1099220A1 (es) |
HR (1) | HRP20090547T1 (es) |
IL (1) | IL178928A (es) |
ME (2) | ME02778B (es) |
MX (1) | MXPA06013501A (es) |
MY (1) | MY138868A (es) |
NO (1) | NO338324B1 (es) |
NZ (1) | NZ550931A (es) |
PL (1) | PL1753431T3 (es) |
PT (1) | PT1753431E (es) |
RS (1) | RS51112B (es) |
RU (1) | RU2383343C2 (es) |
SA (1) | SA05260133B1 (es) |
SI (1) | SI1753431T1 (es) |
TW (1) | TWI355269B (es) |
UA (1) | UA81732C2 (es) |
UY (1) | UY28901A1 (es) |
WO (1) | WO2005112934A1 (es) |
ZA (1) | ZA200609110B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2278511B1 (es) * | 2005-07-28 | 2008-06-16 | Laboratorios Almirall S.A. | Comprimidos con perfil de disolucion mejorado. |
EP3039424B1 (en) | 2013-08-28 | 2020-07-29 | Crown Bioscience, Inc. (Taicang) | Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
MXPA02004366A (es) * | 1999-11-05 | 2002-11-07 | Astrazeneca Ab | Derivados de quinazolina como inhibidores vegf. |
GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
KR100419555B1 (ko) * | 2000-05-29 | 2004-02-19 | 주식회사유한양행 | 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자 |
WO2003074045A1 (fr) * | 2002-03-05 | 2003-09-12 | Eisai Co., Ltd. | Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese |
-
2004
- 2004-05-21 GB GBGB0411378.3A patent/GB0411378D0/en not_active Ceased
-
2005
- 2005-05-09 TW TW094114935A patent/TWI355269B/zh active
- 2005-05-17 UY UY28901A patent/UY28901A1/es unknown
- 2005-05-18 KR KR1020067026603A patent/KR101192935B1/ko active IP Right Grant
- 2005-05-18 ES ES05744858T patent/ES2330025T3/es active Active
- 2005-05-18 AT AT05744858T patent/ATE439841T1/de active
- 2005-05-18 JP JP2007517415A patent/JP4740947B2/ja active Active
- 2005-05-18 RS RSP-2009/0458A patent/RS51112B/sr unknown
- 2005-05-18 EP EP05744858A patent/EP1753431B1/en active Active
- 2005-05-18 BR BRPI0511253A patent/BRPI0511253B8/pt active IP Right Grant
- 2005-05-18 CN CN2005800162448A patent/CN101031303B/zh active Active
- 2005-05-18 UA UAA200613289A patent/UA81732C2/ru unknown
- 2005-05-18 AU AU2005244650A patent/AU2005244650B2/en active Active
- 2005-05-18 SA SA05260133A patent/SA05260133B1/ar unknown
- 2005-05-18 PL PL05744858T patent/PL1753431T3/pl unknown
- 2005-05-18 SI SI200530793T patent/SI1753431T1/sl unknown
- 2005-05-18 WO PCT/GB2005/001931 patent/WO2005112934A1/en active Application Filing
- 2005-05-18 DE DE602005016105T patent/DE602005016105D1/de active Active
- 2005-05-18 DK DK05744858T patent/DK1753431T3/da active
- 2005-05-18 US US11/596,979 patent/US8067427B2/en active Active
- 2005-05-18 PT PT05744858T patent/PT1753431E/pt unknown
- 2005-05-18 ME MEP-2009-458A patent/ME02778B/me unknown
- 2005-05-18 MX MXPA06013501A patent/MXPA06013501A/es active IP Right Grant
- 2005-05-18 CA CA2565513A patent/CA2565513C/en active Active
- 2005-05-18 ME MEP-2013-50A patent/ME01505B/me unknown
- 2005-05-18 RU RU2006145357/15A patent/RU2383343C2/ru active Protection Beyond IP Right Term
- 2005-05-18 NZ NZ550931A patent/NZ550931A/en not_active IP Right Cessation
- 2005-05-19 MY MYPI20052271A patent/MY138868A/en unknown
- 2005-05-20 AR ARP050102087A patent/AR049059A1/es not_active Application Discontinuation
-
2006
- 2006-10-29 IL IL178928A patent/IL178928A/en active IP Right Grant
- 2006-11-01 ZA ZA200609110A patent/ZA200609110B/en unknown
- 2006-12-12 NO NO20065735A patent/NO338324B1/no not_active IP Right Cessation
-
2007
- 2007-06-13 HK HK07106372.8A patent/HK1099220A1/xx unknown
-
2009
- 2009-10-13 HR HR20090547T patent/HRP20090547T1/xx unknown
- 2009-10-15 CY CY20091101075T patent/CY1109500T1/el unknown
-
2017
- 2017-11-09 AR ARP170103128A patent/AR110045A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001847A1 (es) | Una formulación sólida de dosificación farmacéutica | |
ES2526606T3 (es) | Composición farmacéutica sólida que comprende amlodipina y losartán | |
CL2007003791A1 (es) | Compuestos derivados de piperidina, inhibidores de la proteina quinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para inhibir el crecimiento celular anormal. | |
ECSP056253A (es) | Composicion farmaceutica que contiene un inhibidor de histona desacetilasa | |
ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
CL2008002430A1 (es) | Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc. | |
BRPI0616694B8 (pt) | processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis | |
BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
RS51563B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM | |
CL2008003405A1 (es) | Compuestos derivados de tienopiridina, inhibidores de la enzima integrasa del vih; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion por vih. | |
EA201200550A1 (ru) | Фармацевтические композиции, включающие bi-1356 и метформин | |
CL2008003798A1 (es) | Compuestos derivados de heterobiciclos aromaticos sustituidos, inhibidores de pi3 quinasa; composicion farmaceutica; utiles en el tratamiento de cancer, melanomas, glioblastomas, entre otras enfermedades. | |
BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
UY30535A1 (es) | Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones. | |
CL2007003540A1 (es) | Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
CL2007002097A1 (es) | Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras. | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
AR061047A1 (es) | Comprimido bicapa para la prevencion de los accidentes cardiovasculares, su uso, y metodo para la prevencion de accidentes cardiovasculares | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
CL2007001826A1 (es) | Compuestos derivados de 2-(amino-sustituido)-benzotiazol-sulfonamida, inhibidores de proteasa, en particular, inhibidores de proteasa de vih; composicion farmaceutica; y uso para tratar o combatir una infeccion o enfermedad asociada con la infeccion de un retrovirus resistente a multiples farmacos. | |
UY31273A1 (es) | Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53 | |
CL2006003449A1 (es) | Compuestos derivados de n-(fluoro-pirazinil)-fenilsulfonamidas; procedimiento de preparacion; compuesto intermediario; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del asma. | |
DOP2006000024A (es) | Tiazolidinonas, su preparación y su uso como medicamento | |
EA200801614A1 (ru) | Фармацевтическая композиция, содержащая монтелукаст | |
CL2010001421A1 (es) | Uso de dronedarona en la preparacion de medicamentos utiles para la prevencion de fibrilacion o aleteo auricular persistentes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |